The big sleeper is tasocitinib, a so-called janus kinase inhibitor, for rheumatoid arthritis and psoriasis.

FORBES: Pfizer's Big Pipeline Hope

Recent examples: molecules to target drug-resistant bacteria and a kinase inhibitor to zap the enzyme responsible for tumor growth.

FORBES: Careers

Today, AVEO (name was changed in 2005) has an interesting multi-kinase inhibitor tivozanib in Phase 3 for renal cell cancer, and their second program is an anti-HGF mAb.

FORBES: AVEO: An early stage VC's perspective

On the FDA's Fast Track and in phase III testing is the company's BAY 43-9006, a small molecule RAF kinase and VEGF inhibitor that inhibits tumor growth for patients with metastatic renal cell carcinoma (advanced kidney cancer).

FORBES: Beware Of Biotechs At Cancer-Cure Prices